Literature DB >> 1393898

Adverse events after hepatitis B vaccination.

P Duclos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1393898      PMCID： PMC1336290     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  21 in total

1.  Hypersensitivity to thiomersal in hepatitis B vaccine.

Authors:  I Noel; A Galloway; F A Ive
Journal:  Lancet       Date:  1991-09-14       Impact factor: 79.321

2.  Immunogenicity of yeast-derived hepatitis B vaccine from two different producers.

Authors:  E Dahl-Hansen; J C Siebke; S S Frøland; M Degré
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

Review 3.  Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years.

Authors:  F E Shaw; D J Graham; H A Guess; J B Milstien; J M Johnson; G C Schatz; S C Hadler; J N Kuritsky; E E Hiner; D J Bregman
Journal:  Am J Epidemiol       Date:  1988-02       Impact factor: 4.897

4.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.

Authors:  L Herroelen; J de Keyser; G Ebinger
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

5.  Reaction to hepatitis B virus vaccine.

Authors:  S D Feldshon; R E Sampliner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

6.  Polyneuropathy associated with administration of hepatitis B vaccine.

Authors:  E F Ribera; A J Dutka
Journal:  N Engl J Med       Date:  1983-09-08       Impact factor: 91.245

7.  Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age.

Authors:  C A Morris; P R Oliver; F Reynolds; J B Selkon
Journal:  Epidemiol Infect       Date:  1989-10       Impact factor: 2.451

8.  Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization.

Authors:  A Cosnes; M L Flechet; J Revuz
Journal:  Contact Dermatitis       Date:  1990-08       Impact factor: 6.600

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

10.  Combined passive-active immunization against the hepatitis B virus of 132 newborns of chronic carrier mothers: long term results.

Authors:  G Delage; S Rémy-Prince; S Ducic; E Pierri; S Montplaisir
Journal:  Pediatr Infect Dis J       Date:  1988-11       Impact factor: 2.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.